JUNEFLECAD 150mg prolonged release capsules LICONSA
flecainide Indicated for: cardiac arrhythmias
C01BC04 Cardiovascular system | Antiarrhythmics, class I and III | Antiarrhythmics, class Ic
letter J · page 5
flecainide Indicated for: cardiac arrhythmias
C01BC04 Cardiovascular system | Antiarrhythmics, class I and III | Antiarrhythmics, class Ic
flecainide Indicated for: cardiac arrhythmias
C01BC04 Cardiovascular system | Antiarrhythmics, class I and III | Antiarrhythmics, class Ic
flecainide Indicated for: cardiac arrhythmias
C01BC04 Cardiovascular system | Antiarrhythmics, class I and III | Antiarrhythmics, class Ic
denosumab Indicated for: osteoporosis; bone metastases; tumor-induced hypercalcemia
risedronic acid Indicated for: osteoporosis
risedronic acid Indicated for: osteoporosis
sitagliptin + metformin Indicated for: type 2 diabetes mellitus
sitagliptin + metformin Indicated for: type 2 diabetes mellitus
sitagliptin Indicated for: type 2 diabetes mellitus
methotrexate Indicated for: cancer; autoimmune inflammatory diseases
L01BA01 Antineoplastic and immunomodulating agents | Antimetabolites | Folic acid analogues
filgotinib Indicated for: inflammatory bowel disease
filgotinib Indicated for: inflammatory bowel disease